Cellanome is a synthetic biology company focused on developing an automated multi-omics platform to enhance the understanding of individual cell behaviors, interactions, and functions. The platform integrates molecular biology, biochemistry, microfluidics, integrated sensors, and genome sequencing to enable researchers to conduct iterative live cell phenotypic and functional assays at scale. This technology broadens the range of cell types and functions accessible to scientists, facilitating novel solutions to complex biological challenges.
Cellanome has made significant strides in the field of synthetic biology by providing tools that allow for massively parallel analysis of cellular responses. This innovation has empowered researchers to explore new questions and gain deeper insights into cellular mechanisms. The company's impact is evident in its ability to link specific cellular responses to various stimuli, advancing the capabilities of biological research and development.
